RAJYALAKSHMI LUTHRA to Gene Expression Regulation, Leukemic
This is a "connection" page, showing publications RAJYALAKSHMI LUTHRA has written about Gene Expression Regulation, Leukemic.
Connection Strength
0.193
-
Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors. Blood. 2016 Mar 10; 127(10):1269-75.
Score: 0.110
-
A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia. PLoS One. 2011; 6(12):e28277.
Score: 0.083